HB 5217 — AN ACT CONCERNING THE USE OF CERTAIN RODENTICIDES.
Last action — REF. BY HOUSE TO COMMITTEE ON Appropriations
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.
Bill Text
What changed in the latest version
230 added · 60 removed230 line(s) added, 60 removed.
House of Representatives General Assembly RaisedFile Bill No.
521798 February Session, 2024 LCOSubstitute House Bill No.
11145217 ReferredHouse toof Representatives, March 25, 2024 The Committee on ENVIRONMENTEnvironment Introducedreported by:through REP.
(ENV)GRESKO ANof ACTthe CONCERNING121st THEDist., USEChairperson OFof CERTAINthe RODENTICIDES.Committee on the part of the House, that the substitute bill ought to pass.
AN ACT CONCERNING THE USE OF CERTAIN RODENTICIDES.
Section22a-50(NEW) ofthe(Effective generalstatutesOctober isamended1, by2024) adding(a) subsectionNo (m)person asshall followsengage (Effectivein fromthe passage):use in this state of any second-generation anticoagulant rodenticide.
(NEW)For (m)purposes Notof laterthis thansection, January"second-generation 1, 2025, the commissioner shall classify all second-generation anticoagulant rodenticides,rodenticide" asmeans restrictedany usepesticide pursuantproduct tocontaining subdivisionany (2)one of subsectionthe (c)following ofactive thisingredients: section.
For the purposes of this subsection, "second-generation anticoagulant rodenticide" means any pesticide product containing any one of the following active ingredients:
Sec.(b) The provisions of subsection (a) of this section shall not apply to:
2.(1) The use of second-generation anticoagulant rodenticides by any state employee who uses second-generation anticoagulant rodenticides for public health activities in accordance with any provision of the Public Health Code and in furtherance of such employee's duties;
(NEW)(2) (EffectiveThe Octoberuse 1,of 2024)second-generation (a)anticoagulant Norodenticides personwhen shallused engageby inany the sale or distribution in this state ofemployee anyfor second-generationthe anticoagulantpurposes rodenticide, as defined in section 22a-50 of theprotecting generalwater statutes,supply assHB5217 amended/ byFile thisNo. act.
For98 purposes1 ofsHB5217 thisFile subsection,No. "engage in the sale or distribution in this state" includes, but is not limited to, the use of the Internet to perform such sale or distribution.
LCO98 No.infrastructure and facilities in a manner that is consistent with all otherwise applicable federal and state laws and regulations and in furtherance of such employee's duties;
1114(3) 1The use of 3second-generation Raisedanticoagulant Billrodenticides No.by a director of health to control mosquito or vector breeding areas in order to protect the public health;
5217(4) (b) The Commissioneruse of Energyany andsecond-generation Environmentalanticoagulant Protectionrodenticides mayfor adopt regulations, in accordance with the provisionseradication of chapternonnative 54invasive ofthespecies generalinhabiting statutes,or found to ensurebe thatpresent theon continuedoffshore useislands of second-generation anticoagulant rodenticides, in accordancea withmanner thethat provisions of section 22a-50 of the general statutes, as amended by this act, is notconsistent reasonablywith expectedall tootherwise resultapplicable infederal significantand adversestate effectslaws toand nontargetregulations; wildlife.
(5) The use of any second-generation anticoagulant rodenticide to control an actual or potential rodent infestation associated with a public health need, as determined by a supporting declaration from the Commissioner of Public Health or a director of health.
For purposes of this section, "public health need" means an urgent, nonroutine situation posing a significant risk to human health in which it is documented that other rodent control alternatives, including nonchemical alternatives, are inadequate to control the rodent infestation;
(6) The use of second-generation rodenticides in any of the following locations:
(A) A medical waste generator;
or (B) any facility registered annually andsubject to inspectionunder Section510ofthefederalFood, Drug and Cosmetic Act, 21 USC 360 et seq., and that is compliant with the federal Insecticide, Fungicide and Rodenticide Act, 7 USC 135 et seq.;
or (7) The use of second-generation anticoagulant rodenticides for agricultural activities.
For purposes of this subdivision, "agricultural activities" additionally includes activities conducted in any of the following locations:
(A) A warehouse used to store foods for human or animal consumption;
(B) An agricultural food production site, including, but not limited sHB5217 / File No.
98 2 sHB5217 File No.
98 to, a slaughterhouse or cannery;
(C) A factory, brewery or winery;
(D) An agricultural production site housing water storage and conveyance facilities;
or (E) An agricultural production site housing rights-of-way and other transportation infrastructure.
(c) The Commissioner of Energy and Environmental Protection may adopt regulations, in accordance with the provisions of chapter 54 ofthe general statutes, to ensure that the continued use of second-generation anticoagulant rodenticides, in accordance with the provisions of section 22a-50 of the general statutes is not reasonably expected to result in significant adverse effects to nontarget wildlife.
(c)(d) Not later than January 1, 2026, the Commissioner of Energy and Environmental Protection shall submit a report, in accordance with the provisions of section 11-4a of the general statutes, to the joint standing committee of the General Assembly having cognizance of matters relating to the environment on the potential implications of the application of existing statutory and regulatory restrictions and licensing requirements for the use of second-generation anticoagulant rodenticides.
(d)(e) Any person who violates the provisions of subsection (a) of this section shall be subject to a civil penalty of not more than five thousand dollarssHB5217 by/ theFile CommissionerNo. of Energy and Environmental Protection for each such violation.
98 3 sHB5217 File No.
98 dollars by the Commissioner of Energy and Environmental Protection for each such violation.
Section 1 fromOctober passage1, 22a-50(m)2024 Sec.New section ENV Joint Favorable Subst.
2sHB5217 October/ 1,File 2024 New section LCO No.
111498 24 ofsHB5217 3File Raised Bill No.
521798 The following Fiscal Impact Statement and Bill Analysis are prepared for the benefit of Purpose:the members of the General Assembly, solely for purposes of information, summarization and explanation and do not represent the intent of the General Assembly or either chamber thereof for any purpose.
ToIn restrictgeneral, thefiscal useimpacts andare salebased ofupon second-generationa rodenticidesvariety inof orderinformational tosources, protectincluding the healthanalyst’s ofprofessional hawksknowledge. and other raptors.
[ProposedWhenever deletionsapplicable, areagency encloseddata inis brackets.consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.
Show all 99 changed lines (59 more)
ProposedOFA additionsFiscal areNote indicatedState byImpact: underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.] LCO No.
1114Agency 3Affected Fund-Effect FY 25 $ FY 26 $ Department of 3Energy and GF - Cost 79,000 66,000 Environmental Protection Department of Energy and GF - Potential 113,000 116,000 Environmental Protection Cost State Comptroller - Fringe GF - Cost At least At least Benefits1 20,000 27,000 Department of Energy and GF - Potential Potential Potential Environmental Protection Revenue Gain Note:
GF=General Fund Municipal Impact:
None Explanation The bill, which bans the use of certain rodenticides with some exceptions, is anticipated to result in a cost to the state of at least $99,000 in FY 25 and $93,000 in FY 26, and a potential revenue gain.
The bill's reporting requirement may result in an additional state cost in FY 25 and FY 26.
It is anticipated that the Department of Energy and Environmental Protection (DEEP) will require one new full-time Environmental Analyst 2 to enforce the bill's ban.
The associated partial year costs in FY 25 total an estimated $99,000 ($49,000 salary, $20,000 fringe benefits in the Office of the State Comptroller, and $30,000 in other expenses including a vehicle).
The full-year annualized costs are anticipated to The fringe benefit costs for most state employees are budgeted centrally in accounts administered by the Comptroller.
The estimated active employee fringe benefit cost associated with most personnel changes is 41.25% of payroll in FY 25.
sHB5217 / File No.
98 5 sHB5217 File No.
98 be $93,000 in FY 26 ($65,000 salary, $27,000 fringe benefits, and $1,000 in other expenses).
The bill may additionally result in a cost in at least FY 25 and FY 26 associated with the requirement to report by January 1, 2026 on, among other topics, the potential effects of the ban, including impacts on raptor health.
While the new Environmental Analyst 2 may be able to write the report, DEEP may choose to engage in thorough research and monitoring of raptor health.
The department anticipates it would hire a State Veterinarian specializing in wildlife, at a cost of approximately $147,000 in FY 25 ($83,000 salary, $34,000 fringe benefits, and $30,000 in other expenses, including a vehicle) and $162,000 in FY 26 ($111,000 salary, $46,000 fringe benefits, and $5,000 in other expenses).
The bill makes a violation of the ban subject to a civil penalty of up to $5,000 per violation, resulting in a potential revenue gain to the General Fund beginning in FY 25.
The extent of the revenue gain depends on the number of violations and the amount of each fine collected.
The Out Years The annualized ongoing fiscal impact identified above would continue into the future subject to inflation and the amount of fines collected.
sHB5217 / File No.
98 6 sHB5217 File No.
98 OLR Bill Analysis sHB 5217 AN ACT CONCERNING THE USE OF CERTAIN RODENTICIDES.
SUMMARY This bill generally prohibits the use of “second-generation anticoagulant rodenticides” in Connecticut (i.e., pesticide products containing brodifacoum, bromadiolone, difenacoum, or difethialone;
see BACKGROUND).
It exempts several uses from the ban, such as by state employees for public health or water supply protection reasons, agricultural activity, or at a medical waste generator location.
Under the bill, a violation of the ban is subject to a civil fine of up to $5,000 per violation by the Department of Energy and Environmental Protection (DEEP).
The bill also allows DEEP to adopt regulations on thecontinueduse oftheserodenticidestoensurethatitisnotreasonably expected to have significant adverse effects on nontarget wildlife.
The regulations must include provisions for the rodenticides’ use if it is necessary to eradicate invasive rodent populationsto protect threatened or endangered species or their habitats.
Lastly, the bill requires, by January 1, 2026, DEEP to report to the Environment Committee on the potential implications of applying existing statutory and regulatory restrictions and licensing requirements on second-generation anticoagulant rodenticide use.
The report must include (1) an analysis of the consistency of applying the restrictions and requirements with federal law;
(2) potential effects, including improved raptor health and expenses and delays that the changes may have on public health and agriculture in Connecticut;
and (3) required administrative resources to oversee the restrictions.
EFFECTIVE DATE:
October 1, 2024 sHB5217 / File No.
98 7 sHB5217 File No.
98 RODENTICIDE EXEMPTIONS The bill exempts the following uses from the ban:
1.
by a state employee within the scope of his or her duties (a) for public health activities conducted in accordance with the Public Health Code or (b) to protect water supply infrastructure and facilities in a way that is consistent with federal and state laws and regulations;
2.
by a health director to control mosquito or vector breeding areas to protect public health;
3.
in a location that is a medical waste generator or a drug or device production facility that is annually registered, subject to inspection under the federal Food, Drug, and Cosmetic Act, and complies with the Federal Insecticide, Fungicide, and Rodenticide Act;
4.
to eradicate nonnative invasive species inhabiting or found on offshore islands in a way that is consistent with federal and state laws and regulations;
5.
to control an actual or potential rodent infestation associated with a public health need that the public health commissioner or a health director determines by a supporting declaration;
and 6.
for agricultural activities, including those done at a warehouse for storing foods for human or animal consumption;
a factory, brewery, or winery;
an agricultural food production site (e.g., slaughterhouse or cannery);
or an agricultural production site housing water storage or conveyance facilities or rights-of-way and other transportation infrastructure.
Under the bill, a “public health need” is an urgent, nonroutine situation posing a significant human health risk.
It must also be documented that other rodent control methods, including nonchemical sHB5217 / File No.
98 8 sHB5217 File No.
98 ones, are inadequate to control the infestation.
BACKGROUND Second-Generation Anticoagulant Rodenticide Most rodenticides are anticoagulant compounds that interfere with blood clotting and cause death from excessive bleeding.
Second- generation anticoagulants were developed to control rodents that are resistant to first-generation anticoagulants.
These pesticides are more likely to be effective after a single feeding and may remain in animal tissuelonger thanfirst-generationproducts.They areregisteredonlyfor the commercial and structural pest control markets and are currently under federal Environmental Protection Agency registration review.
COMMITTEE ACTION Environment Committee Joint Favorable Substitute Yea 33 Nay 1 (03/08/2024) sHB5217 / File No.
98 9
Show all 99 changed rows (59 more)
View plain text versions (3)
- File No. 98 View text pdf
- Raised Bill View text Current pdf
- Substitute ENV Joint Favorable Substitute pdf
Action History
-
REF. BY HOUSE TO COMMITTEE ON Appropriations
-
FILE NO. 98
-
HOUSE CALENDAR NUMBER 94
-
FAV. RPT., TABLED FOR HOUSE CALENDAR
-
RPTD. OUT OF LCO
-
REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 03/25/24
-
FILED WITH LCO
-
Joint Favorable Substitute
-
PUBLIC HEARING 0228
-
REF. TO JOINT COMM. ON Environment
Sponsors
- David Michel · Primary
- Aundre Bumgardner · Primary
- Joseph P. Gresko · Primary
- Mary M. Mushinsky · Primary
- Lucy Dathan · Primary
- Frank Smith · Primary
- James Sanchez · Primary
- Christine Palm · Primary
- Devin R. Carney · Primary
- Patricia A. Dillon · Primary
- Hector Arzeno · Primary
- Julie Kushner · Primary
- Moira Rader · Primary
- Maria P. Horn · Primary
- Kevin Ryan · Primary
- Brandon Chafee · Primary
- Jan Hochadel · Primary
- Josh Elliott · Primary
- Anne M. Hughes · Primary
- Jane M. Garibay · Primary
- Jillian Gilchrest · Primary
- Sarah Keitt · Primary
- James Sanchez · Primary
- Geraldo C. Reyes · Primary
Sponsorship breakdown
Export CSV (upgrade) →24 sponsors · 0 co-sponsors · 163 not signed on
Sponsors (24)
- David Michel
- Aundre Bumgardner Democratic
- Joseph P. Gresko Democratic
- Mary M. Mushinsky Democratic
- Lucy Dathan Democratic
- Frank Smith Democratic
- James Sanchez Democratic
- Christine Palm
- Devin R. Carney Republican
- Patricia A. Dillon Democratic
- Hector Arzeno Democratic
- Julie Kushner Democratic
- Moira Rader Democratic
- Maria P. Horn Democratic
- Kevin Ryan
- Brandon Chafee Democratic
- Jan Hochadel Democratic
- Josh Elliott Democratic
- Anne M. Hughes Democratic
- Jane M. Garibay Democratic
- Jillian Gilchrest Democratic
- Sarah Keitt Democratic
- James Sanchez Democratic
- Geraldo C. Reyes Democratic
Co-sponsors (0)
None.
Not signed on (163)
163 members have not signed on to this bill.
Show all 163 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors HB 5217?
- HB 5217 is sponsored by David Michel, Aundre Bumgardner (Democratic), Joseph P. Gresko (Democratic), Mary M. Mushinsky (Democratic), Lucy Dathan (Democratic), Frank Smith (Democratic), James Sanchez (Democratic), Christine Palm, Devin R. Carney (Republican), Patricia A. Dillon (Democratic), Hector Arzeno (Democratic), Julie Kushner (Democratic), Moira Rader (Democratic), Maria P. Horn (Democratic), Kevin Ryan, Brandon Chafee (Democratic), Jan Hochadel (Democratic), Josh Elliott (Democratic), Anne M. Hughes (Democratic), Jane M. Garibay (Democratic), Jillian Gilchrest (Democratic), Sarah Keitt (Democratic), and Geraldo C. Reyes (Democratic).
- What is the current status of HB 5217?
- This bill died with 2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HB 5217?
- Track HB 5217 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 5217
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 5217
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →